Carregant...
Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratification
Despite recent refinements to the 21-gene g score, allowing a better identification of patients who may derive no benefit from the addition of adjuvant chemotherapy to that of endocrine therapy, patients with early breast cancer still stand to be over-treated in the setting of clinical and/or genomi...
Guardat en:
| Publicat a: | NPJ Breast Cancer |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group UK
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6715716/ https://ncbi.nlm.nih.gov/pubmed/31482106 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-019-0123-9 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|